Arterial Stiffness is Associated with Oxidative Stress and Endothelial Activation Among Persons with Treated HIV in Zambia
Overview
Authors
Affiliations
Background: Cardiovascular disease (CVD) prevalence is rising among persons with HIV (PLWH) in sub-Saharan Africa. Oxidative stress and endothelial activation, resulting in reduced vascular compliance, are contributors to CVD risk. However, there is a paucity of vascular health data in this population.
Objectives: To assess the relationships of oxidative stress and endothelial activation with vascular stiffness among PLWH.
Method: Fifty-four PLWH on antiretroviral therapy > 5 years and 57 HIV-negative controls, all aged 18-45 years, were enrolled from the University Teaching Hospital, Lusaka, Zambia. Oxidative stress was measured by nitrotyrosine, a peroxynitrite biomarker, and endothelial activation by soluble intercellular adhesion molecule-1 (sICAM-1) plasma levels. Vascular compliance was measured using carotid-radial pulse wave velocity (crPWV) and arterial stiffness index (crASI).
Results: PLWH had higher sICAM-1 levels (median 345 ng/mL) compared to controls (275 ng/mL, < 0.01), as well as higher nitrotyrosine levels (297 versus 182 nM; = 0.02). Median crPWV was similar between the groups, but PLWH had higher crASI (2.4 versus 2.2 cm/ms; < 0.05). After adjusting for age, fat mass, and blood pressure, the estimated effect of a one unit increase in nitrotyrosine on crPWV were twofold higher in the PLWH, but neither reached significance. In a model pooling all participants, there were significant differences in the relationship of nitrotyrosine with crPWV and crASI by HIV status.
Conclusion: PLWH in sub-Saharan Africa had significantly greater oxidative stress and endothelial activation compared to HIV-negative individuals. These factors may contribute to increased arterial stiffness and higher CVD prevalence in this population.
Arterial stiffness in adults with Long COVID in sub-Saharan Africa.
Theresa C, Katebe B, Shibao C, Kirabo A Physiol Rep. 2024; 12(17):e70029.
PMID: 39251404 PMC: 11386233. DOI: 10.14814/phy2.70029.
Hahka T, Slotkowski R, Akbar A, VanOrmer M, Sembajwe L, Ssekandi A Circ Res. 2024; 134(4):459-473.
PMID: 38359096 PMC: 10885774. DOI: 10.1161/CIRCRESAHA.123.324077.
Jakubiak G, Cieslar G, Stanek A Antioxidants (Basel). 2022; 11(5).
PMID: 35624720 PMC: 9137700. DOI: 10.3390/antiox11050856.